Kyukwang Kim
Overview
Explore the profile of Kyukwang Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim K, Khazan N, McDowell J, Snyder C, Miller J, Singh R, et al.
PLoS One
. 2024 Dec;
19(12):e0314564.
PMID: 39621651
Ovarian cancer is the leading cause of death among gynecologic malignancies. Despite recent advancements in targeted therapies such as PARP inhibitors, recurrence is common and frequently resistant to existing therapies....
2.
Ciccioli M, Kim K, Khazan N, Khoury J, Cooke M, Miller M, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):240.
PMID: 39169412
Circulating Tumor Cells (CTCs) may serve as a non-invasive source of tumor material to investigate an individual's disease in real-time. The Parsortix PC1 System, the first FDA-cleared medical device for...
3.
Kim K, Khazan N, Rowswell-Turner R, Singh R, Moore T, Strawderman M, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473335
Forchlorfenuron (FCF) is a widely used plant cytokinin that enhances fruit quality and size in agriculture. It also serves as a crucial pharmacological tool for the inhibition of septins. However,...
4.
Templeman A, Miller M, Cooke M, OShannessy D, Gurung Y, Pereira T, et al.
J Circ Biomark
. 2023 Aug;
12:26-33.
PMID: 37601320
Introduction: The Parsortix PC1 system, Food and Drug Administration (FDA) cleared for use in metastatic breast cancer (MBC) patients, is an epitope-independent microfluidic device for the capture and harvest of...
5.
Kim K, Kim M, Lee A, Song S, Kang J, Eom J, et al.
Cell Rep
. 2023 Jul;
42(7):112778.
PMID: 37453058
The regulatory effect of non-coding large-scale structural variations (SVs) on proto-oncogene activation remains unclear. This study investigated SV-mediated gene dysregulation by profiling 3D cancer genome maps from 40 patients with...
6.
Joo J, Cho S, Hong S, Min S, Kim K, Kumar R, et al.
Nucleic Acids Res
. 2023 Apr;
51(11):5377-5395.
PMID: 37013988
Inter-chromosomal interactions play a crucial role in genome organization, yet the organizational principles remain elusive. Here, we introduce a novel computational method to systematically characterize inter-chromosomal interactions using in situ...
7.
Han S, Kim K, Park S, Lee A, Chun H, Jung I
NAR Genom Bioinform
. 2023 Jan;
4(4):lqac095.
PMID: 36601579
Genetic differences inferred from sequencing reads can be used for demultiplexing of pooled single-cell RNA-seq (scRNA-seq) data across multiple donors without WGS-based reference genotypes. However, such methods could not be...
8.
Kang C, Choi B, Kim S, Sun C, Yoon S, Kim K, et al.
Haematologica
. 2022 Sep;
108(1):257-260.
PMID: 36106393
No abstract available.
9.
Kim K, Jung I
Comput Struct Biotechnol J
. 2021 Jun;
19:3149-3159.
PMID: 34141136
Hi-C and capture Hi-C have greatly advanced our understanding of the principles of higher-order chromatin structure. In line with the evolution of the Hi-C protocols, there is a demand for...
10.
Kim K, Kim M, Kim Y, Lee D, Jung I
Semin Cell Dev Biol
. 2021 May;
121:161-170.
PMID: 33992531
The mammalian genome is highly packed into the nucleus. Over the past decade, the development of Hi-C has contributed significantly to our understanding of the three-dimensional (3D) chromatin structure, uncovering...